Neogen Chemicals Limited.

Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; advance intermediates; and chemistries, such as alkylation, amination, oxidation, dehalogenation, silylation, anhydrous HF and HBr reactions, halex reaction, suzuki coupling, hydrogenation, and biocatalysis. It serves pharmaceuticals, agrochemicals, electronics, water treatment, construction, polymers, flavours & fragrances and energy storage. The company also exports its products to 36 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.

Market cap

₹7,159 cr

P/E (TTM)

203.9

P/B (latest)

8.8

ROE (TTM)

3.5%

ROCE (TTM)

6.8%

Sales CAGR 3y

7.9%

PAT CAGR 3y

-16.8%

Debt / equity

1.63x

Promoter

53%

Dividend yield

0.04%

Size

Micro

Codes

NEOGEN · 542665

52-week ₹979.8 – ₹2,488.4 · ADTV ₹43.8 cr · price-only.